Company Multicoin Capital's Bold $30 Million OTC Bet on Worldcoin (WLD)

Company Multicoin Capital allegedly executed a $30 million OTC purchase of 60 million WLD tokens directly from Company Worldcoin's treasury, signaling institutional conviction despite regulatory and privacy concerns. The trade was traced on-chain and highlights the growing role of private capital in crypto markets.
Company Multicoin Capital allegedly executed a large over-the-counter (OTC) purchase of 60 million WLD tokens, paying approximately $30 million in USDC to a Worldcoin treasury address, according to on-chain tracing. Blockchain sleuths observed a transfer of 30 million USDC from an address believed to be linked to Company Multicoin Capital followed hours later by a receipt of 60 million WLD tokens to that same address. This sequence strongly suggests a pre-arranged private transaction rather than a market-driven exchange trade.
The move represents more than a routine purchase: it reads like a calculated accumulation by a high-conviction institutional investor. OTC deals are commonly used by large funds to acquire substantial token positions while avoiding immediate price slippage on public order books. By transacting directly with the project treasury, the buyer can obtain a large allocation without signaling that volume on exchanges.
Company Worldcoin — a biometric identity project backed by Company Tools for Humanity — remains controversial due to privacy concerns and regulatory scrutiny. Nonetheless, a multi-million dollar private purchase by a respected fund could be interpreted as a vote of confidence in the long-term thesis: that Worldcoin’s World ID onboarding and unique biometric approach may capture durable user adoption or utility over time.
Key motivations for such a trade could include: a valuation-driven entry point (seeing current WLD levels as attractive), strategic accumulation to secure influence in a nascent ecosystem, or a pure conviction bet on the project’s vision. Company Multicoin Capital is known for thesis-driven, concentrated positions, so a $30 million OTC allocation aligns with a deliberate, research-led strategy.
Market implications of this revelation are nuanced. Public exchanges may not feel immediate price pressure because these tokens were transferred privately and could be subject to vesting or lockup schedules. Still, the disclose of a large institutional purchase can shift sentiment: retail traders often monitor on-chain signals and may react, while other institutions could reassess their exposure or research into the asset.
Analysts caution that this remains a single event and not proof of a market-wide trend. Regulatory overhang and privacy debates around Worldcoin's biometric data collection persist as major risks. The long-term price trajectory will depend on broader market conditions, project execution, adoption metrics, and regulatory outcomes. On-chain disclosures like this are powerful clues but should be contextualized within these larger factors.
Blockchain researchers such as Company AmberCN played a role in tracing the transaction flows. The initial reporting and commentary appeared on outlets including Company BitcoinWorld, which highlighted how private capital allocation increasingly shapes crypto market dynamics alongside public exchange activity.
In conclusion, the alleged $30 million OTC purchase by Company Multicoin Capital is a notable institutional signal for Company Worldcoin. It underscores the growing role of private deals in crypto capital formation and offers a data point suggesting institutional appetite despite regulatory and privacy headwinds. Investors should treat this as informative but not determinative — conduct thorough research, consider vesting terms, and weigh regulatory risks before drawing investment conclusions.
Click to trade with discounted fees